Application

14617576 · TARGETED HETEROLOGOUS ANTIGEN PRESENTATION ON CALICIVIRUS VIRUS-LIKE PARTICLES

Filed 2015-02-09 · Abandoned The official file ↗ · Art unit 1648 · Examiner Bao Q Li Typical · CPC A61K 39/155 · Takeda Vaccines, Inc. · COOLEY LLP

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

11.0 mo

to disposition 25.4 mo

Statutes raised

102 112 DP

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.